Protocol for Creating Antibodies with Complex Fluorescence Spectra.
Journal
Bioconjugate chemistry
ISSN: 1520-4812
Titre abrégé: Bioconjug Chem
Pays: United States
ID NLM: 9010319
Informations de publication
Date de publication:
16 06 2021
16 06 2021
Historique:
pubmed:
20
5
2021
medline:
28
8
2021
entrez:
19
5
2021
Statut:
ppublish
Résumé
Fluorescent antibodies are a workhorse of biomedical science, but fluorescence multiplexing has been notoriously difficult due to spectral overlap between fluorophores. We recently established proof-of-principal for fluorescence Multiplexing using Spectral Imaging and Combinatorics (MuSIC), which uses combinations of existing fluorophores to create unique spectral signatures for increased multiplexing. However, a method for labeling antibodies with MuSIC probes has not yet been developed. Here, we present a method for labeling antibodies with MuSIC probes. We conjugate a DBCO-Peg5-NHS ester linker to antibodies and a single-stranded DNA "docking strand" to the linker and, finally, hybridize two MuSIC-compatible, fluorescently labeled oligos to the docking strand. We validate the labeling protocol with spin-column purification and absorbance measurements. We demonstrate the approach using (i) Cy3, (ii) Tex615, and (iii) a Cy3-Tex615 combination as three different MuSIC probes attached to three separate batches of antibodies. We created single-, double-, and triple-positive beads that are analogous to single cells by incubating MuSIC probe-labeled antibodies with protein A beads. Spectral flow cytometry experiments demonstrate that each MuSIC probe can be uniquely distinguished, and the fraction of beads in a mixture with different staining patterns are accurately inferred. The approach is general and might be more broadly applied to cell-type profiling or tissue heterogeneity studies in clinical, biomedical, and drug discovery research.
Identifiants
pubmed: 34009954
doi: 10.1021/acs.bioconjchem.1c00220
pmc: PMC8845489
mid: NIHMS1776825
doi:
Substances chimiques
Antibodies
0
DNA, Single-Stranded
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1156-1166Subventions
Organisme : NCI NIH HHS
ID : R21 CA196418
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM141891
Pays : United States
Références
J Biomed Opt. 2012 Jul;17(7):076005
pubmed: 22894488
Hum Genomics. 2019 Aug 1;13(1):34
pubmed: 31370908
Nat Rev Microbiol. 2008 May;6(5):339-48
pubmed: 18414500
Nat Med. 2014 Apr;20(4):436-42
pubmed: 24584119
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4009-14
pubmed: 23412337
Oncoimmunology. 2018 Mar 15;7(6):e1431084
pubmed: 29872556
Nature. 2018 Apr 5;556(7699):108-112
pubmed: 29590089
Genes Cells. 2002 Sep;7(9):881-7
pubmed: 12296819
Bioconjug Chem. 2016 Jan 20;27(1):217-25
pubmed: 26689321
Cell Discov. 2020 May 4;6:31
pubmed: 32377375
Nature. 2019 Apr;568(7751):235-239
pubmed: 30911168
Clin Cancer Res. 2015 Jan 15;21(2):249-57
pubmed: 25421725
Sci Rep. 2019 Dec 19;9(1):19471
pubmed: 31857644
Curr Protoc Chem Biol. 2016 Dec 7;8(4):251-264
pubmed: 27925668
ACS Comb Sci. 2018 Nov 12;20(11):653-659
pubmed: 30339749
Science. 2019 Mar 29;363(6434):1463-1467
pubmed: 30923225
Memo. 2017;10(4):244-247
pubmed: 29250205
Adv Biochem Eng Biotechnol. 2005;95:245-65
pubmed: 16080271
Trends Immunol. 2019 Nov;40(11):1011-1021
pubmed: 31645299
Elife. 2018 Jul 11;7:
pubmed: 29993362
Transl Sci. 2016 Mar;2(3):
pubmed: 27284574
NPJ Biofilms Microbiomes. 2016 Nov 23;2:3
pubmed: 28649397
Ann Biomed Eng. 2006 Jun;34(6):1061-8
pubmed: 16783661
Neurol Neuroimmunol Neuroinflamm. 2020 Aug 12;7(6):
pubmed: 32817412
Nat Methods. 2014 Apr;11(4):417-22
pubmed: 24584193
Cell. 2018 Aug 9;174(4):968-981.e15
pubmed: 30078711
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
Cell. 2016 May 5;165(4):780-91
pubmed: 27153492
J Histochem Cytochem. 2000 May;48(5):653-62
pubmed: 10769049
Cell Host Microbe. 2017 Apr 12;21(4):433-442
pubmed: 28407481
Clin Biochem Rev. 2011 Nov;32(4):177-95
pubmed: 22147957
Oncol Res Treat. 2017;40(7-8):404-408
pubmed: 28693023
J Biomed Opt. 2008 May-Jun;13(3):031220
pubmed: 18601544
Nat Methods. 2016 Mar;13(3):257-62
pubmed: 26808668
Nature. 2018 May;557(7706):595-597
pubmed: 29789748
Sci Rep. 2019 Jul 18;9(1):10426
pubmed: 31320709
Science. 2018 Aug 3;361(6401):
pubmed: 30072512
J Biomed Opt. 2014 Jan;19(1):10901
pubmed: 24441941
Nat Med. 2020 Jan;26(1):39-46
pubmed: 31873309
J Biomed Opt. 2013 Aug;18(8):86012
pubmed: 23966226
Adv Exp Med Biol. 2020;1255:175-193
pubmed: 32949400
Nat Med. 2015 Aug;21(8):846-53
pubmed: 26248267
Front Med (Lausanne). 2017 Dec 08;4:227
pubmed: 29276709
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11982-7
pubmed: 23818604
Pharmacol Ther. 2016 Jan;157:120-4
pubmed: 26615782
Adv Cancer Res. 2018;139:185-207
pubmed: 29941105
Syst Appl Microbiol. 2012 Dec;35(8):496-502
pubmed: 22521573
J Clin Invest. 2016 Sep 1;126(9):3447-52
pubmed: 27525433
Cell. 2013 Feb 14;152(4):714-26
pubmed: 23415222
Cell Mol Immunol. 2020 Jun;17(6):650-652
pubmed: 32346099
Immunol Cell Biol. 2021 Jan;99(1):97-106
pubmed: 32741011
J Immunol Methods. 2018 Feb;453:3-10
pubmed: 28322863
PLoS One. 2017 Nov 30;12(11):e0188878
pubmed: 29190747